Literature DB >> 6296214

Immunologic cross-reactivity between different albumin-bound isocyanates.

X Baur.   

Abstract

Sera of six workers with conclusive evidence for IgE-mediated sensitization to isocyanates were used for evaluation of immunologic cross-reactivities among eight different isocyanate-protein conjugates. In all cases RAST and/or skin-test investigations revealed the presence of IgE antibodies reacting specifically with HSA conjugated with those isocyanates to which workers were exposed as well as with other isocyanates with which they had not been in contact. By the RAST inhibition technique, moderate to strong mutual cross-reactivities between all tested isocyanate-HSA conjugates--even between aromatic and aliphatic ones--could be demonstrated in tests with five sera. The magnitudes of cross-reactivities differed, however, from one patient to another. One serum contained IgE antibodies that were almost completely specific to TDI-HSA; with this serum only weak cross-reactivities with other isocyanate conjugates could be demonstrated. These results indicate the predominance of closely related antigenic determinants in HSA conjugated with different isocyanates. The common antibody-binding regions are obviously recognized to different extents by antibodies of clinically sensitized workers, indicating individual differences in specificities and avidities of antibody populations. Nearly complete lack of IgE binding of ovalbumin-bound TDI in RAST and RAST inhibition indicates carrier-specific antigenicity of isocyanate-protein conjugates. In addition, since unmodified HSA did not bind IgE, antigenic determinants of the conjugates studied should be predominantly formed by the isocyanate-protein bond regions and concurrently by neighboring amino acid residues of the HSA molecule.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6296214     DOI: 10.1016/0091-6749(83)90100-8

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  12 in total

Review 1.  New aspects of isocyanate asthma.

Authors:  X Baur
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 2.  Anaphylactoid reactions to intravenous solutions used for volume substitution.

Authors:  J Ring
Journal:  Clin Rev Allergy       Date:  1991 Fall-Winter

Review 3.  Developments in laboratory diagnostics for isocyanate asthma.

Authors:  Adam V Wisnewski
Journal:  Curr Opin Allergy Clin Immunol       Date:  2007-04

4.  Isocyanate-induced asthma: results of inhalation tests with TDI, MDI and methacholine.

Authors:  C Vogelmeier; X Baur; G Fruhmann
Journal:  Int Arch Occup Environ Health       Date:  1991       Impact factor: 3.015

5.  Occupational asthma and extrinsic alveolitis due to isocyanates: current status and perspectives.

Authors:  O Vandenplas; J L Malo; M Saetta; C E Mapp; L M Fabbri
Journal:  Br J Ind Med       Date:  1993-03

6.  Antigenic changes in human albumin caused by reactivity with the occupational allergen diphenylmethane diisocyanate.

Authors:  Adam V Wisnewski; Jian Liu; Carrie A Redlich
Journal:  Anal Biochem       Date:  2010-02-01       Impact factor: 3.365

Review 7.  Respiratory and other hazards of isocyanates.

Authors:  X Baur; W Marek; J Ammon; A B Czuppon; B Marczynski; M Raulf-Heimsoth; H Roemmelt; G Fruhmann
Journal:  Int Arch Occup Environ Health       Date:  1994       Impact factor: 3.015

8.  A clinical and immunological study on 92 workers occupationally exposed to anhydrides.

Authors:  X Baur; A B Czuppon; I Rauluk; F B Zimmermann; B Schmitt; M Egen-Korthaus; N Tenkhoff; P O Degens
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

9.  Inhibition of acetylcholinesterase by diisocyanates and its spontaneous reactivation.

Authors:  M Dewair; X Baur; R Mauermayer
Journal:  Int Arch Occup Environ Health       Date:  1983       Impact factor: 3.015

10.  Is specific IgE antibody analysis feasible for the diagnosis of methylenediphenyl diisocyanate-induced occupational asthma?

Authors:  Lygia Therese Budnik; Alexandra M Preisser; Hjalmar Permentier; Xaver Baur
Journal:  Int Arch Occup Environ Health       Date:  2012-04-28       Impact factor: 3.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.